Skip to main content
. 2023 Oct 27;13(11):1112. doi: 10.3390/metabo13111112

Figure 2.

Figure 2

Study characteristics and overview of reported biomarkers in the included studies. (A) Characteristics of the included studies. (B) Metabolite and lipid reporting across the studies. HC: healthy control, HCC: hepatocellular carcinoma, LC: liver cirrhosis, MS: mass spectrometry, MSI: Metabolomics Standards Initiative, ND: not described, NMR: nuclear magnetic resonance.